<DOC>
	<DOCNO>NCT02224274</DOCNO>
	<brief_summary>There grow evidence standard dual antiplatelet therapy acetylsalicylic acid ( ASA ) clopidogrel effective setting therapeutic hypothermia cardiac arrest normothermic patient . The reason probably slower gastrointestinal motility , absorption liver metabolism require clopidogrel take action . Since ticagrelor faster intestinal absorption need liver metabolism expect effect good even patient therapeutic hypothermia cardiac arrest . Patients treat therapeutic hypothermia cardiac arrest percutaneous coronary intervention randomise two group . One treat ASA clopidogrel ASA ticagrelor . Blood sample collect 2 , 4 , 12 , 22 48 hour P2Y12 inhibitor administration . Platelet function measure VerifyNow P2Y12 assay Multiplate ADPTest . Differences group analyse . Hypothesis : Antiplatelet therapy ticagrelor effective therapy clopidogrel comatose survivor cardiac arrest treat therapeutic hypothermia percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Antiplatelet Therapy After Cardiac Arrest</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Female male 18 year old Unconscious survivor cardiac arrest treat therapeutic hypothermia Acute coronary syndrome ( NSTEMI STEMI ) reason cardiac arrest PCI stent implantation Provision inform consent prior study specific procedure impossible subject unconscious moment inclusion Use P2Y12 inhibitor last 10 day Use prasugrel 48 hour load dose P2Y12 inhibitor Use eptifibatide 48 hour load dose P2Y12 inhibitor Thrombocytopenia ( &lt; 50*109/L ) Allergic reaction acetylsalicylic acid , clopidogrel ticagrelor Ticagrelor contraindication : previous intracranial bleeding , active pathological bleeding , moderate severe hepatic impairment , heart rate &lt; 40/min presentation Suspected confirm pregnancy Use bivalirudin 48 hour load dose P2Y12 inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Antiplatelet Therapy</keyword>
	<keyword>Cardiac Arrest</keyword>
	<keyword>Therapeutic hypothermia</keyword>
	<keyword>Myocardial infarction ( STEMI NSTEMI )</keyword>
</DOC>